11/26
02:01 pm
avr
Anteris Technologies Global (NASDAQ:AVR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Anteris Technologies Global (NASDAQ:AVR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
06:00 am
avr
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
Medium
Report
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
11/12
05:52 pm
avr
Anteris Announces Results for the Third Quarter of 2025
Medium
Report
Anteris Announces Results for the Third Quarter of 2025
11/3
07:00 am
avr
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Medium
Report
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
10/30
12:25 pm
avr
Anteris Technologies Global (NASDAQ:AVR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Anteris Technologies Global (NASDAQ:AVR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/28
06:08 pm
avr
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
Low
Report
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
10/27
05:43 pm
avr
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Medium
Report
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
10/27
08:43 am
avr
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
Medium
Report
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
10/15
09:18 am
avr
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Medium
Report
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
9/19
02:30 am
avr
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
Low
Report
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
9/11
09:31 am
avr
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders [Yahoo! Finance]
Neutral
Report
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders [Yahoo! Finance]
9/11
08:50 am
avr
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
Medium
Report
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders